Anne von Gottberg
Overview
Explore the profile of Anne von Gottberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
265
Citations
12390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
du Plessis M, Mikhari R, de Gouveia L, Duma N, Lovelock T, Lawrence C, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):417-426.
PMID: 40023798
We reviewed Corynebacterium spp. infection cases reported in South Africa during 2015-2023. We analyzed 84 isolates from 83 patients with C. diphtheriae, as well as 1 C. belfantii and 3...
2.
Meiring S, Quan V, Mashau R, Perovic O, Magobo R, Smith M, et al.
Lancet Microbe
. 2025 Feb;
:100989.
PMID: 40020700
Background: Infections are among the top causes of neonatal mortality, particularly in low-income and middle-income countries. We aimed to describe the clinical characteristics of neonates diagnosed with culture-confirmed bloodstream infections...
3.
Nabeemeeah F, Sabet N, Otwombe K, Hlongwane K, Mlambo L, Moloantoa T, et al.
BMJ Open
. 2025 Jan;
14(12):e080553.
PMID: 39806691
Purpose: In the setting of an established childhood pneumococcal vaccination programme with immediate initiation and treatment of antiretroviral therapy (ART) for people living with HIV (PLWH), the risk of adult...
4.
Lombard B, Cohen C, von Gottberg A, Dushoff J, Pulliam J, van Schalkwyk C
PLoS One
. 2025 Jan;
20(1):e0315476.
PMID: 39746096
Background: Monitoring trends in multiple infections with SARS-CoV-2, following several pandemic waves, provides insight into the biological characteristics of new variants, but also necessitates methods to understand the risk of...
5.
Ntozini B, Walaza S, Metcalf B, Hazelhurst S, de Gouveia L, Meiring S, et al.
J Infect Dis
. 2024 Dec;
PMID: 39737783
Background: Group B Streptococcus (GBS) is a leading cause of neonatal meningitis and sepsis and an important cause of disease in adults. Capsular polysaccharide and protein-based GBS vaccines are currently...
6.
Shaw D, Torreblanca R, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, et al.
Lancet Digit Health
. 2024 Dec;
PMID: 39709282
Microbiology reference laboratories perform a crucial role within public health systems. This role was especially evident during the COVID-19 pandemic. In this Viewpoint, we emphasise the importance of microbiology reference...
7.
Garcia Quesada M, Peterson M, Bennett J, Hayford K, Zeger S, Yang Y, et al.
Lancet Infect Dis
. 2024 Dec;
PMID: 39706205
Background: Widespread use of pneumococcal conjugate vaccines (PCVs) has reduced vaccine-type invasive pneumococcal disease (IPD). We describe the serotype distribution of IPD after extensive use of ten-valent PCV (PCV10; Synflorix,...
8.
Bennett J, Knoll M, Kagucia E, Garcia Quesada M, Zeger S, Hetrich M, et al.
Lancet Infect Dis
. 2024 Dec;
PMID: 39706204
Background: Pneumococcal conjugate vaccines (PCVs) that are ten-valent (PCV10) and 13-valent (PCV13) became available in 2010. We evaluated their global impact on invasive pneumococcal disease (IPD) incidence in all ages....
9.
Moyes J, Makhazi M, Walaza S, Ntombela P, Moosa F, von Gottberg A, et al.
Influenza Other Respir Viruses
. 2024 Dec;
18(12):e70034.
PMID: 39648401
Background: Surveillance programmes for influenza and other respiratory pathogens are important to generate vaccine effectiveness (VE) estimates and to inform vaccine composition. We aimed to explore the feasibility and acceptability...
10.
Cohen C, du Plessis M, Martinson N, Moyes J, Walaza S, Wolter N, et al.
J Infect Dis
. 2024 Nov;
231(2):e328-e336.
PMID: 39542652
Background: Approaches for determining whether influenza vaccination prevents infection, attenuates illness, or both are important for developing improved vaccines. We estimated influenza infection incidence and evaluated symptom ascertainment methodologies in...